Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Illumina, Inc.
  6. News
  7. Summary
    ILMN   US4523271090

ILLUMINA, INC.

(ILMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Illumina : SVB Leerink Adjusts Illumina's Price Target to $420 from $425, Keeps Market Perform Rating

10/19/2021 | 12:08pm EST


ę MT Newswires 2021
All news about ILLUMINA, INC.
11/25Vitrolife To Distribute Genomic Testing Kits In Asia Pacific Region
MT
11/24INSIDER SELL : Illumina
MT
11/17Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in ..
PR
11/17Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in ..
CI
11/16EU Expected to Raise Objections to Illumina's Completed $8 Billion Grail Purchase
MT
11/16INSIDER SELL : Illumina
MT
11/16Illumina, Genetic Alliance Launch $120 Million Program Expanding Genome Sequencing Acce..
MT
11/16Illumina defends Grail deal; expects EU formal objections on Wednesday
RE
11/16Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity ..
PR
11/08Baird Adjusts Illumina's Price Target to $437 From $493, Maintains Neutral Rating
MT
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Financials (USD)
Sales 2021 4 424 M - -
Net income 2021 673 M - -
Net Debt 2021 225 M - -
P/E ratio 2021 84,4x
Yield 2021 -
Capitalization 57 798 M 57 798 M -
EV / Sales 2021 13,1x
EV / Sales 2022 11,5x
Nbr of Employees 7 825
Free-Float 79,8%
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 369,79 $
Average target price 441,73 $
Spread / Average Target 19,5%
EPS Revisions
Managers and Directors
Francis A. deSouza President, Chief Executive Officer & Director
Sam A. Samad Chief Financial Officer & Senior Vice President
John Wendell Thompson Chairman
Phillip G. Febbo Chief Medical Officer
Alex Aravanis CTO, Head-Research & Product Development
Sector and Competitors